Clinical Trial Update: Biaxin Based Antibiotic Therapy in Previously Untreated, Advanced Stage Indolent Lymphoma

View source ↗

Summary

A trial evaluating a Biaxin (clarithromycin)-based antibiotic regimen for previously untreated, advanced-stage indolent lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Indolent Non-hodgkin Lymphoma

Drugs mentioned

• Biaxin (clarithromycin)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Lymphoma | Status: COMPLETED